[Epidemiology of long COVID: a preliminary report. German short version of the original KCE report]
Wolf S, Erdos J
Record ID 32018001652
Original Title: Epidemiologie von long-Covid: ein vorläufiger bericht. Deutsche kurzfassung zum gleichnamigen KCE-Bericht
Authors' objectives: Due to the expected increase in long COVID cases, social consequences have to be considered in addition to the impairments in daily life for the affected persons and their families. The aim of the cooperation with the Belgian HTA institute, KCE, was to provide an overview of long COVID prevalences and possible risk factors, as well as of the consequences for everyday life.
Authors' results and conclusions: Currently available data on the epidemiology of long COVID revealed that 5-36% of non-hospitalised COVID-19 patients and 39-72% of hospitalised patients reported long-lasting or recurrent symptoms one to three months after the acute infection. After three to six months, there was a slight decrease in prevalences in both patient populations (2-21% and 51-68%, respectively). After more than six months, 13-25% and up to 60% of the non-hospitalised and hospitalised patients respectively, still reported persistent symptoms. The most commonly reported symptoms among long COVID patients were fatigue (16-98%), shortness of breath (10-93%) and headache (9-91%) one to three months after acute infection, and fatigue (16-78%), cognitive impairment (13-55%) and respiratory problems (16-21%) after three to six months. Furthermore, the studies suggested that the female gender and a high number of symptoms during the acute infection may favour the occurrence of long COVID symptoms. In addition, some long COVID patients experienced impairments in activities of daily living and reduced social participation (e.g. inability to work).
Authors' recomendations: Until today, it remains unclear to what extent the reported long COVID symptoms can be distinguished from similar symptoms of other diseases and to what extent they are novel long-term symptoms (type and duration) compared with the long-term consequences of other severe infectious diseases. For this reason, sufficiently large, prospective, and, if possible, comparative cohort studies are recommended for future research initiatives. In addition, transparent communication of long COVID prevalences, including any potential uncertainties in the data, will be important in the future.
Authors' methods: A systematic search of 11 databases and a hand search were performed. Considering the predefined inclusion and exclusion criteria, 28 studies in 29 publications were included, comprising 22 cohort studies and six cross-sectional surveys.
Project Status: Completed
URL for project: https://www.hta.lbg.ac.at/page/spaet-und-langzeitfolgen-nach-einer-sars-cov-2-erkrankung-update/en
Year Published: 2021
URL for published report: https://eprints.aihta.at/1321/1/HTA-Projektbericht_Nr.135a.pdf
URL for additional information: https://eprints.aihta.at/1321/
English language abstract: There is no English language summary available
Publication Type: Full HTA
- Time Factors
- Fatigue Syndrome, Chronic
- Recovery of Function
- Risk Assessment
- Long COVID
- Post-Covid Syndrome
- long-term consequences
- risk factors
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Garnisongasse 7/20, A-1090 Vienna, Austria
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: HTA Austria - Austrian Institute for Health Technology Assessment GmbH
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.